OpenResearchAlpha

bioRxiv · 17 Nov 2026

Pathogenic human autoantibodies target the soluble CASPR2 ectodomain to induce network hyperexcitability

Debora Serrenho, Nuno del Villar, Vitor Bueno, Dominique Fernandes, Quin Tutor-New, Takahisa Kanekiyo, Elinor Wing, Robyn Williams, Stephan Steinke, Luis F. Ribeiro, Paulo Pinheiro, Ester Coutinho, Sarosh R Irani, Ana Luisa Carvalhoh-index 33

0
Citations
no database records one yet
0
Citations in 2026
so far
33
Leading author's h-index
Ana Luisa Carvalho, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The mechanisms by which autoantibodies contribute to antibody-mediated neurological diseases remain poorly understood. Autoantibodies targeting the extracellular domain of CASPR2 are found in patients with clinical features consistent with hyperexcitability, including neuromyotonia and seizures. These antibodies are reported to disrupt the functions of membrane-embedded CASPR2. However, given that CASPR2 is also detected in cerebrospinal fluid (CSF), which contains CASPR2 autoantibodies, targeting of CSF-shed CASPR2 may represent an additional pathogenic mechanism, introducing a novel paradigm of soluble antigen modulation by autoantibodies. Here, we found that patient-derived polyclonal and monoclonal CASPR2 antibodies enhanced neuronal network excitability and selectively amplified excitatory synaptic transmission in human and rat primary cortical neurons. In addition, CASPR2 antibodies impaired calcium homeostasis and altered the intrinsic properties of both excitatory and inhibitory neurons. Notably, these antibodies depleted CASPR2 from both neuronal culture medium and patient CSF, suggesting targeting of the shed CASPR2 ectodomain. Knockdown of plasma membrane calcium ATPase 2 (PMCA2), a reported target of the CASPR2 ectodomain, abrogated the observed effects of CASPR2 antibodies. Together, our findings identify shed CASPR2 as a underrecognized pathogenic target of CASPR2 autoantibodies and demonstrate that its neutralization disrupts PMCA2-mediated calcium regulation, driving neuronal network hyperexcitability. More broadly, we identify the neuronal sheddome as a source of autoantibody targets and soluble protein neutralization as a novel disease mechanism, highlighting shed CASPR2 as a potential biomarker and therapeutic target.

Neuroscience

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Ana Luisa Carvalho has the highest h-index among the authors (33).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (14)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
Pathogenic human autoantibodies target the soluble CASPR2 ectodomain to induce network hyperexcitability - QAI OpenResearch